Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.637
-0.093 (-12.75%)
At close: Apr 28, 2026, 4:00 PM EDT
0.678
+0.041 (6.48%)
After-hours: Apr 28, 2026, 4:23 PM EDT
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $2.12 million as of April 28, 2026. Its market cap has decreased by -69.40% in one year.
Market Cap
2.12M
Enterprise Value
-2.03M
1-Year Change
-69.40%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $2.12M, a decrease of -98.57%. That is a compound annual growth rate of -56.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.43M | -59.49% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Virax Biolabs Group | 3.18M |
| GeoVax Labs | 3.15M |
| Decoy Therapeutics | 2.89M |
| Oragenics | 2.78M |
| Scinai Immunotherapeutics | 2.56M |
| HCW Biologics | 2.53M |
| Calidi Biotherapeutics | 2.50M |
| Bone Biologics | 2.44M |